Department of Molecular Imaging and Nuclear Medicine, Tianjin Medical University Cancer Institute and Hospital; National Clinical Research Center for Cancer; Key Laboratory of Cancer Prevention and Therapy; Tianjin's Clinical Research Center for Cancer,Tianjin 300060, P.R. China.
Tianjin Medical University, Tianjin 300203, P.R. China.
Bioconjug Chem. 2021 Feb 17;32(2):318-327. doi: 10.1021/acs.bioconjchem.0c00694. Epub 2021 Feb 5.
Metal-organic frameworks (MOFs) derivatives had been widely explored in electronic and environmental fields, but rarely evaluated in the biomedical applications. Herein, Fe-N codoped carbon (FeNC) nanoparticles were synthesized and characterized via facile pyrolysis of precursor ZIF-8 (Fe/Zn) nanoparticles, and their potential applications in tumor therapy were assessed in this investigation both in vitro and in vivo. After PAA (sodium polyacrylate) modification, the FeNC@PAA nanoparticles were able to initiate a Fe-based Fenton-like reaction to generate ·OH and O for chemodynamic therapy (CDT) and O evolution. Meanwhile, the porphyrin-like metal center in the FeNC@PAA nanoparticles could be used as a photosensitizer for photodynamic therapy (PDT) of tumors, which could be enhanced by O generated in CDT. Furthermore, the FeNC@PAA nanoparticles were also found to be effective in photothermal therapy (PTT) with a photothermal conversion efficiency of 29.15%, owing to a high absorbance in the near-infrared region (NIR). In conclusion, the synthesized FeNC@PAA nanoparticles exhibited promising applications in O evolution and CDT/PDT/PTT synergistic treatment of tumors.
金属-有机骨架(MOFs)衍生物在电子和环境领域得到了广泛的探索,但在生物医学应用中很少被评估。在此,通过简单的前驱体 ZIF-8(Fe/Zn)纳米粒子的热解合成并表征了 Fe-N 共掺杂碳(FeNC)纳米粒子,并在体外和体内评估了它们在肿瘤治疗中的潜在应用。经过 PAA(聚丙烯酸钠)修饰后,FeNC@PAA 纳米粒子能够引发基于 Fe 的类芬顿反应,产生用于化学动力学治疗(CDT)和 O 演化的·OH 和 O。同时,FeNC@PAA 纳米粒子中的卟啉样金属中心可用作肿瘤的光动力治疗(PDT)的光敏剂,这可以通过 CDT 中产生的 O 得到增强。此外,由于在近红外区域(NIR)具有高吸收率,FeNC@PAA 纳米粒子还被发现可有效用于光热治疗(PTT),其光热转换效率为 29.15%。总之,合成的 FeNC@PAA 纳米粒子在 O 演化和 CDT/PDT/PTT 协同治疗肿瘤方面表现出了有前景的应用。
J Mater Chem B. 2022-11-3
ACS Appl Mater Interfaces. 2021-3-3
Molecules. 2025-6-30
J Nanobiotechnology. 2025-2-20
J Nanobiotechnology. 2023-9-27
View (Beijing). 2023-4
Breast Cancer (Dove Med Press). 2023-2-3
J Nanobiotechnology. 2022-5-2